Quest Diagnostics
$14.26 B
Share price
Change (1 day)
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Market capitalization of Quest Diagnostics (DGX)

Market cap: $14.26 Billion

As of April 2024 Quest Diagnostics has a market cap of $14.26 Billion. This makes Quest Diagnostics the world's 1192th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Quest Diagnostics from 2001 to 2024

End of year Market Cap

Year Market cap Change
2024$14.26 B-7.99%
2023$15.50 B-12.99%
2022$17.81 B-16.05%
2021$21.22 B32.15%
2020$16.06 B13.07%
2019$14.20 B26.35%
2018$11.24 B-16.26%
2017$13.42 B5.36%
2016$12.74 B25.24%
2015$10.17 B5.35%
2014$9.65 B25.25%
2013$7.70 B-16.43%
2012$9.22 B0.73%
2011$9.15 B-0.59%
2010$9.21 B-16.75%
2009$11.06 B8.99%
2008$10.15 B-1.13%
2007$10.27 B-0.09%
2006$10.27 B0.62%
2005$10.21 B5.66%
2004$9.66 B28.64%
2003$7.51 B34.85%
2002$5.57 B-19.05%
2001$6.88 B

End of Day market cap according to different sources

On Apr 20th, 2024 the market cap of Quest Diagnostics was reported to be:

$14.26 Billion
by Yahoo Finance info icon info icon
$14.26 Billion
by CompaniesMarketCap info icon info icon
$14.21 Billion
by Nasdaq info icon info icon
$14.26 Billion
by Iex Cloud info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$16.94 B 18.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.82 B-80.20%๐Ÿ‡บ๐Ÿ‡ธ USA
$14.92 M-99.90%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.72 B-87.89%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.85 B-37.93%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$55.83 M-99.61%๐Ÿ‡บ๐Ÿ‡ธ USA